OMER Omeros Corp

Price (delayed)

$4.27

Market cap

$247.42M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.97

Enterprise value

$717.74M

Omeros is a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market and orphan indications targeting inflammation, complement-mediated diseases, disorders of the central nervous ...

Highlights
Omeros's quick ratio has increased by 47% YoY and by 19% from the previous quarter
OMER's equity has dropped by 186% since the previous quarter
The debt is up by 31% since the previous quarter

Key stats

What are the main financial stats of OMER
Market
Shares outstanding
57.94M
Market cap
$247.42M
Enterprise value
$717.74M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$90.15M
EBITDA
-$89.22M
Free cash flow
-$142.08M
Per share
EPS
-$1.97
Free cash flow per share
-$2.42
Book value per share
-$1.13
Revenue per share
$0
TBVPS
$7.44
Balance sheet
Total assets
$437.49M
Total liabilities
$508.82M
Debt
$472.15M
Equity
-$71.33M
Working capital
$221.9M
Liquidity
Debt to equity
-6.62
Current ratio
4.76
Quick ratio
4.03
Net debt/EBITDA
-5.27
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-26.4%
Return on equity
N/A
Return on invested capital
-11.4%
Return on capital employed
-23.8%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

OMER stock price

How has the Omeros stock price performed over time
Intraday
0.47%
1 week
10.34%
1 month
13.26%
1 year
-18.51%
YTD
30.58%
QTD
5.17%

Financial performance

How have Omeros's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$167.85M
Net income
-$121.3M
Gross margin
N/A
Net margin
N/A
The net income has contracted by 3% from the previous quarter
Omeros's operating income has decreased by 2.3% YoY and by 2% from the previous quarter

Growth

What is Omeros's growth rate over time

Valuation

What is Omeros stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has declined by 4.8% since the previous quarter
OMER's equity has dropped by 186% since the previous quarter

Efficiency

How efficient is Omeros business performance
The ROA has contracted by 10% from the previous quarter
Omeros's ROIC has decreased by 4.6% from the previous quarter

Dividends

What is OMER's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for OMER.

Financial health

How did Omeros financials performed over time
The total assets is 14% less than the total liabilities
The current ratio has soared by 59% YoY and by 16% from the previous quarter
Omeros's quick ratio has increased by 47% YoY and by 19% from the previous quarter
OMER's equity has dropped by 186% since the previous quarter
Omeros's debt to equity has plunged by 178% YoY but it has soared by 54% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.